The role of silver nanoparticles alone and combined with imipenem on carbapenem-resistant Klebsiella pneumoniae
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Jiangyan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical University, Changhuai Road 287, Bengbu, Anhui Province 233030, Chi…. Hauptthemen laut MEDLINE: Imipenem, Klebsiella pneumoniae, Silver, Microbial Sensitivity Tests. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Province University Outstanding Youth Research Project, Outstanding Youth Fund Project of the First Affiliated Hospital of Bengbu Medical University.
Abstract (Originalsprache)
Aims
Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections poses a significant threat to human health, necessitating urgent development of new antimicrobial agents. Silver nanoparticles (AgNPs), which are among the most widely used engineered nanomaterials, have been extensively studied. However, the impact of AgNPs on CRKP and the potential for drug resistance development remain inadequately explored. Methods and results In this study, broth dilution method was used to determine the minimum inhibitory concentration (MIC) was determined using the broth dilution method. Results indicated MIC values of 93.1 ± 193.3 µg ml−1 for AgNPs, 2.3 ± 5.1 µg ml−1 for AgNO3, and 25.1 ± 48.3 µg ml−1 for imipenem (IMI). The combined inhibitory effect of AgNPs and IMI on CRKP was assessed using the checkerboard method. Moreover, after 6–20 generations of continuous culture, the MIC value of AgNPs increased 2-fold. Compared to IMI, resistance of Kl. pneumoniae to AgNPs developed more slowly, with a higher fold increase in MIC observed after 20 generations. Whole-genome sequencing revealed four nonsynonymous single nucleotide polymorphism mutations in CRKP after 20 generations of AgNP treatment.
Conclusion
We have demonstrated that AgNPs significantly inhibit CRKP isolates and enhance the antibacterial activity of imipenem against Kl. pneumoniae. Although the development of AgNP resistance is gradual, continued efforts are necessary for monitoring and studying the mechanisms of AgNP resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical University, Changhuai Road 287, Bengbu, Anhui Province 233030, China.
- Anhui Province Key Laboratory of Basic and Translational Research of Inflammation-related Diseases, Changhuai Road 287, Bengbu, Anhui Province 233030, China.
- Bengbu Medical University, Donghaidadao 2600, Bengbu, Anhui Province 233030, China.
ORCID-Profile: Jiangyan Li
Förderung
- National Natural Science Foundation of China
- Anhui Province University Outstanding Youth Research Project
- Outstanding Youth Fund Project of the First Affiliated Hospital of Bengbu Medical University
- High-level Science and Technology Innovation Team of the First Affiliated Hospital of Bengbu Medical University
- Anhui Province University Key Research Project
Zitieren
APA
Li, J., Yu, L., Wang, R., Lan, J., Li, M., Qiao, Y., Tao, Z., Lü, H., Wang, F., Fang, Q., & Guo, P. (2024). The role of silver nanoparticles alone and combined with imipenem on carbapenem-resistant Klebsiella pneumoniae. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae077
Vancouver
Li J, Yu L, Wang R, Lan J, Li M, Qiao Y, et al. The role of silver nanoparticles alone and combined with imipenem on carbapenem-resistant Klebsiella pneumoniae. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae077
BibTeX
@article{Li2024,
author = {Li, Jiangyan and Yu, Lian and Wang, Ruirui and Lan, Jiaqi and Li, Ming and Qiao, Yan and Tao, Zhaoyu and Lü, Hezuo and Wang, Fengchao and Fang, Qiang and Guo, Pu},
title = {The role of silver nanoparticles alone and combined with imipenem on carbapenem-resistant Klebsiella pneumoniae},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae077}
}
EUVIMED